Condition: Lassa Fever · Sponsor: International AIDS Vaccine Initiative
A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults and Children Residing in West Africa
This description comes directly from the study's public registry record.
Gaudensia Mutua · +254-719-043-000 · gmutua@iavi.org
Babalwa Jongihlati · NAP · BJongihlati@iavi.org
Always discuss trial participation with your own doctor first.
| Noguchi Memorial Institute for Medical Research (NMIMR) | Accra, Ghana | Recruiting |
| PREVAIL_ John F. Kennedy Medical Center (JFK) | Monrovia, Liberia | Recruiting |
| Walter Reed Program - Nigeria | Wuse, Nigeria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05868733